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Summary
Inborn defects in nucleotide excisionDNA repair (NER) can paradoxically result in elevated cancer incidence (xeroderma pig-
mentosum [XP]) or segmental progeria without cancer predisposition (Cockayne syndrome [CS] and trichothiodystrophy
[TTD]). We report generation of a knockin mouse model for the combined disorder XPCS with a G602D-encoding mutation
in the Xpd helicase gene. XPCS mice are the most skin cancer-prone NER model to date, and we postulate an unusual NER
dysfunction that is likely responsible for this susceptibility. XPCS mice also displayed symptoms of segmental progeria, in-
cluding cachexia and progressive loss of germinal epithelium. Like CS fibroblasts, XPCS and TTD fibroblasts from human
and mouse showed evidence of defective repair of oxidative DNA lesions that may underlie these segmental progeroid
symptoms.Introduction
The highly conserved nucleotide excision DNA repair pathway
(NER) removes a wide diversity of helix-distorting DNA lesions,
including UV-induced photoproducts, bulky chemical adducts,
and several forms of oxidative lesions (Brooks et al., 2000; de
Laat et al., 1999; Furuta et al., 2002; Hoeijmakers, 2001; Spivak
and Hanawalt, 2006). NER is composed of two subpathways,
global genome NER (GG-NER) and transcription-coupled NER
(TC-NER), that differ mainly in the mechanism of damage recog-
nition. In GG-NER, the hHR23B/XPC complex, assisted for
some lesions by the XPE/UV-DDB complex, functions as the
main damage sensor and initiator of the NER reaction. In TC-
NER, blockage of transcribing RNA-PolII is believed to trigger
the repair reaction (Batty and Wood, 2000; Hanawalt, 2002;
Svejstrup, 2003; van den Boom et al., 2002). NER involvesCANCER CELL 10, 121–132, AUGUST 2006 ª2006 ELSEVIER INC. DOI 1sequential binding of w30 proteins in a ‘‘cut and patch’’-type
reaction that takes w4 min to complete (de Laat et al., 1999;
Hoogstraten et al., 2002).
The consequences of inborn defects in NER are highlighted
by rare, autosomal recessive syndromes xeroderma pigmento-
sum (XP), Cockayne syndrome (CS), and trichothiodystrophy
(TTD) (Bootsma et al., 2002; Broughton et al., 2001; Lehmann,
2003). XP patients display prominent sun sensitivity, elevated
(>1000-fold) frequency of sun-induced skin cancer, and >10-
fold risk of internal tumors (Kraemer et al., 1987). Enigmatically,
the sun sensitivity in CS and TTD does not result in enhanced
cancer risk. Instead, these syndromes are characterized by
postnatal developmental delay, microcephaly, skeletal abnor-
malities, progressive mental degeneration, sensorineural deaf-
ness, ataxia, spasticity and gait anomalies, demyelination, brain
calcifications, hypogonadism, and death usually before pubertyS I G N I F I C A N C E
The notion that defects in NER give rise to either segmental progeria (CS and TTD) or cancer predisposition (XP) led to the hypothesis that
premature aging can protect against cancer, likely via activation of cell death or senescence pathways following genotoxic insult.
However, the rare combinedcases of XPCSandXPTTD inwhichboth cancer andprogeria coemerge present a challenge to this notion.
Using amousemodel for XPCS, we show that cancer and segmental progeria can be differentially modulated by one amino acid sub-
stitution in a single protein, the XPD helicase component of the transcription/repair factor TFIIH.0.1016/j.ccr.2006.05.027 121
A R T I C L E(Itin et al., 2001; Nakura et al., 2000; Nance and Berry, 1992;
Rapin et al., 2000). In addition to these features reminiscent of
premature aging, TTD patients display typical brittle hair and
nails and scaling skin (ichthyosis). However, in exceptional
cases, NER deficiency presents as a combined syndrome,
XPCS (Lafforet and Dupuy, 1978) or XPTTD (Broughton et al.,
2001), in which the hallmarks of both XP and CS or TTD coexist.
Because these disorders are so rare (only nine XPCS and two
XPTTD patients reported) and clinically heterogeneous, firm
conclusions about the relationship between cancer and aging
in NER disorders have so far been elusive.
While enhanced mutagenesis is accepted as the mechanistic
basis of elevated skin cancer incidence in XP (Cleaver, 2000;
Hoeijmakers, 2001; Lehmann, 2005), the molecular deficiency
underlying segmental progeria remains obscure as well as the
relationship between cancer and aging (Mitchell et al., 2003).
Mutations in genes encoding three of the ten components of
the multifunctional protein complex TFIIH—XPB, XPD, and
p8/TTD-A—are associated with the widest clinical diversity,
ranging from XP to XPCS, TTD, and XPTTD (Broughton et al.,
1994, 2001; Giglia-Mari et al., 2004; Weeda et al., 1997). In
DNA repair via the NER pathway, the XPB and XPD helicase
subunits of TFIIH, together with p8/TTD-A, cooperate to unwind
DNA surrounding the lesion (Coin et al., 2006). TFIIH also opens
promoters for RNA polymerase (Pol)II (Schaeffer et al., 1993),
and RNA PolI transcription (Bradsher et al., 2002; Hoogstraten
et al., 2002) and mediates some forms of activated transcription
(Keriel et al., 2002). In addition, TFIIH has putative roles in p53-
dependent apoptosis (Wang et al., 1996), cell cycle regulation
(Harper and Elledge, 1998), and resistance to oxidative stress
(de Boer et al., 2002; de Waard et al., 2003, 2004). To what ex-
tent any of these defects, whether in DNA repair, transcription,
or cell cycle control, contribute to disease etiology in vivo is still
largely unknown, mostly due to limitations of existing biochem-
ical and cellular assays to predict systemic and/or time-depen-
dent pathology.
The aim of this study was to investigate the mechanism(s) of
TFIIH-associated segmental progeria and cancer predisposition
in experimentally tractable mouse models of the XPD-asso-
ciated progeroid disorders TTD and XPCS. Previously, we
mimicked a known human TTD-associated point mutation
(XPDR722W) in the mouse Xpd locus. Homozygous XpdTTD
mice constitute an excellent model for human TTD displaying
the hallmark cutaneous symptoms as well as segmental proge-
roid features (de Boer et al., 1998a, 2002). Further reduction of
DNA repair capacity by inactivation of theXpa gene results in ac-
celeration of TTD features and death within 3 weeks after birth
(de Boer et al., 2002). Here, we report the generation and char-
acterization of an XpdXPCS mouse model engineered by genoco-
pying the XPDG602D allele found in the patient XPCS2.
Results
Generation of viable XpdXPCS knockin mice
Because the XPD protein is essential for viability (de Boer et al.,
1998b) and previous attempts to mimic the XPDXPCS (XpdG602D)
point mutation failed to yield a viable mouse mutant (J.-O.A., un-
published data), we adopted a minimally invasive knockin strat-
egy as depicted in Figures 1A–1C. Briefly, the Xpd locus was
targeted by homologous recombination in ES cells with the
G602D-encoding point mutation together with a loxP-flanked122neomycin resistance cassette in the 30UTR. Progeny of chimeric
mice generated with the targeted ES cells heterozygous for the
XPCS-neo-LoxP G602D Xpd allele (Figures 1B and 1D) were
subsequently crossed with Cre recombinase-expressing mice
to generate the XPCS allele (Figures 1C and 1E). RT-PCR from
testes RNA of heterozygous animals demonstrated comparable
mRNA expression between wt and mutant alleles (Figure 1F).
XpdXPCS/XPCS homozygous mutant offspring from matings be-
tween heterozygous animals were viable and observed at the
expected Mendelian frequency. Despite similar Xpd mRNA
levels, TFIIH levels were significantly reduced to w50% of wt
in primary XPCS mouse embryonic fibroblasts (MEFs; Figures
1G and 1H). Reduced TFIIH was also observed in cells from pa-
tient XPCS2 (Botta et al., 2002). Because Xpdwt/wt and heterozy-
gous XpdXPCS/wt mice were indistinguishable in all aspects
investigated, we conclude that the mutant allele has no
dominant effect over the wild-type allele, consistent with the
recessive nature of the disease. For simplicity, Xpdwt/wt and
XpdXPCS/wt mice will hereafter be referred to as ‘‘wt’’ and homo-
zygous mutants as ‘‘XPCS.’’ Unless noted otherwise, all the
mice used in this study were in a 129Ola/C57BL/6/FVB hybrid
genetic background.
Repair of UV-induced damage in XPCS cells
Fibroblasts from the XPCS patient XPCS2, a hemizygote with
XPDG602D expression from one allele, display defects in both
GG-NER and TC-NER and are hypersensitive to killing by UV
(Broughton et al., 1995). We tested various DNA repair charac-
teristics of primary MEFs using the UV-induced unscheduled
DNA synthesis (UDS) and recovery of RNA synthesis (RRS)
assays, which reflect GG-NER and TC-NER activities, respec-
tively. Similar to XPA and CSB cells, which lack TC-NER capac-
ity entirely, XPCS cells had no detectable RRS (Figure 2B). How-
ever, unlike XPA cells, which lack GG-NER altogether, XPCS
cells retained w30% UDS activity (Figure 2A). Consistent with
a NER defect and similar to cells from patient XPCS2, primary
XPCS MEFs were hypersensitive to UV irradiation (Figure 2C).
We next examined the kinetics of NER factor accumulation at
locally induced UV damage in the nuclei of wt and mutant cells.
The accumulation and retention of NER factors at sites of local
damage mainly reflects GG-NER of UV-induced 6-4 photoprod-
ucts, a process which is completed inw2 hr in wt cells (D.H., un-
published data). We monitored Xpc, the main damage sensor in
GG-NER, and the p62 subunit of TFIIH by immunofluorescence
15 min and 3 hr after application of local UV damage. In XPA and
XPCS MEFs, we consistently observed accumulation of both
XPC and TFIIH at sites of UV irradiation within 15 min of UV ex-
posure at concentrations similar to those observed in wt MEFs.
Three hours after UV, when NER factors were no longer detect-
able at local damage in wt cells, XPC and TFIIH remained con-
centrated at local damage in XPA, in XPCS, and to a lesser ex-
tent in partially NER-defective TTD MEFs (Figure 2D and data
not shown). Interestingly, in double mutant XPAjXPCS cells,
XPC displayed normal accumulation, whereas TFIIH binding at
local damage was either weak (w50% of cells) or below the level
of detection (w50% of cells) (Figure 2D). Similar results were
obtained in double mutant XPAjTTD cells (data not shown), indi-
cating that the absence of XPA reduces binding of TFIIH to
damage when carrying XPCS (XPDG602D) or TTD (XPDR722W)
alterations.CANCER CELL AUGUST 2006
A R T I C L EFigure 1. XPCS knockin targeting of the mouse Xpd locus
A–C: Schematic representation of the wild-type (A), targeted (B), and Cre
recombined (C) Xpd loci. Coding exons are numbered. Causative G602D
mutation is indicated by a vertical arrow and LoxP sequences by filled tri-
angles. Primers F1, F2, and R are indicated by arrows. TGA, translational
stop codon; P(A), polyadenylation signal. H, HindIII; E, EcoRI; Hp, HpaI; Sf,
SfiI.
D: Southern blot of EcoRI-digested genomic DNA from wt and XPCS-
neo-LoxP recombinant ES clones hybridized with a unique 30 probe located
outside the targeting construct (A–C, thick line). wt allele, 6.5 kb; targeted
allele, 5.1 kb.
E: Verification of Cre excision of the neo gene and genotyping of progeny
by PCR using primers F2 and R as indicated in C. After excision by Cre, the
XPCS and wt alleles yield products of 529 and 400 bp, respectively.
F: RT-PCR amplification of mRNA originating from XpdXPCS/wt testis using
primers R and F1. Note the comparable amounts of 1514 bp wt and 1643
bp XPCS products.
G: Upper panel: indirect immunofluorescence of the p62 subunit of TFIIH in
wt and XPCS primary MEFs (indicated by asterisks). Lower panel: phaseCANCER CELL AUGUST 2006Hypersensitivity to UV irradiation in XPCS mice
Photosensitivity is a common symptom of NER deficiency inde-
pendent of skin cancer predisposition. In contrast to wt controls,
XPCS mice exposed to UV-B light at the environmentally rele-
vant dose of 200 J/m2/day for 4 days developed erythema within
5 days (data not shown). Histological analysis of skin sections of
XPCS mice sacrificed 1 week after the start of UV-B treatment
revealed pronounced epidermal hyperplasia, consisting of an in-
creased number of viable cell layers (acanthosis) and hyperemia
(dilated capillaries, filled with blood), reflecting the observed
skin erythema (Figure 3A). Neither erythema nor hyperplasia
was observed in the UV-exposed skin of heterozygous mice
and in the unexposed skin of XPCS mice (Figure 3A). In conclu-
sion, the XPCS mutation induces severe photosensitivity in mice
similar to that of patient XPCS2.
Enhanced cancer predisposition and a unique repair
defect in XPCS mice
The XPCS patient XPCS2 first presented with a skin tumor al-
ready at 2.5 years of age (Lafforet and Dupuy, 1978; Linden-
baum et al., 2001), suggestive of a pronounced cancer predis-
position. In order to determine skin cancer susceptibility, we
exposed XPCS animals daily to a low UV-B dose of 100 J/m2/
day (equivalent to w70% of the minimal erythemal dose for
XPCS, w50% for XPA, w10% for wt). NER-deficient XPA
mice in a C57BL/6 genetic background were included as a pos-
itive control. Four out of ten XPCS mice and zero out of five XPA
mice developed corneal opacity 10 weeks after the start of the
UV-B treatment; at 11 weeks, all ten XPCS mice and three out
of five XPA mice showed corneal opacity. Cutaneous effects
(i.e., erythema) were observed in UV-treated XPCS but not
XPA mice at 7 weeks after the start of the treatment (three out
of ten mice). Within 17 weeks, all ten XPCS mice developed
skin and/or eye tumors on UV-B exposed areas (Figures 3B–
3D; Table 1), whereas none of the XPA mice carried tumors at
this time point. At 23 weeks, the first tumor-bearing XPA mouse
was observed, with all five XPA mice carrying tumors by 31
weeks. During the 40 week experiment, none of the wild-type
or heterozygous control mice developed tumors or other skin le-
sions. A complete overview of the observed tumor response is
given in Table 1. A summary of published UVB carcinogenesis
experiments in NER mouse models is presented in Table S1 in
the Supplemental Data available with this article online.
The uniform, rapid onset of tumors in XPCS mice and the ab-
sence of clear strain-associated changes in cancer predisposi-
tion in XPA (Table S1) and TTD mice (exposure of TTD mice in
C57/bl6 background to a daily dose of 80 J/m2 revealed no can-
cer predisposition; J.J. and H. Rebel, unpublished data) indi-
cates that the XPDG602D-encoding mutation, rather than the ge-
netic background, is causative of the cancer predisposition.
Thus, among NER-deficient mice, XPCS appears the most
prone to UV-induced skin cancer.
We next explored why XPCS mice are more cancer prone
than XPA mice, which lack the ability to repair UV-induced
DNA lesions by NER altogether. In wt cells, the ‘‘cut’’ (incision)
contrast image of the same microscopic field; wt cell is labeled with silicon
beads (arrow). Scale bars, 5 mm.
H: Quantification of immunofluorescence from the p62 subunit of the TFIIH
complex in wt and XPCS cells. p value indicates the significance of the dif-
ference between wt and XPCS cells analyzed on the same microscopic
slide. Error bars indicate SEM.123
A R T I C L EFigure 2. UV-induced DNA damage repair characteristics of XPCS cells
A: UV-induced DNA repair synthesis capacity (UV-UDS) in primary MEFs of the indicated genotypes. p value indicates the significance of the difference
between wt and CSB to XPCS, XPA, and XPCSjXPA as well as between XPCS and XPA mutants. Error bars indicate SEM.
B: UV-induced recovery of RNA synthesis (UV-RRS) in primary MEFs. p value indicates the significance of the difference between all of themutants and the wt.
Error bars indicate SEM.
C: Composite UV survival from several independent experiments containing multiple primary MEF lines per genotype. Error bars lie within symbol size and
indicate SEM between different experiments.
D: Kinetics of UV-induced NER factor accumulation. XPC and the p62 subunit of TFIIH were visualized by indirect immunofluorescence at 15 min and 3 hr after
local UV irradiation of primary MEFs of the indicated genotypes. Note the lack of observable TFIIH accumulation at UV-irradiated sites in nuclei of cells doubly
mutant for XPA and XPCS. Scale bars, 1 mm.and ‘‘patch’’ steps of NER-dependent DNA repair synthesis (as
measured by UDS) are coupled to each other as well as to lesion
removal, while in UV-irradiated XPCS patient-derived cells, inci-
sion activity is high despite relatively low UDS and virtually ab-
sent lesion removal (Berneburg et al., 2000; Theron et al.,
2005), indicating an uncoupling of these repair parameters. To
determine if this uncoupling is also present in cells from the
XPCS mouse model, we followed the phosphorylated histone
H2AX (gH2AX) as a marker of incision activity 3 hr after UV treat-
ment of nondividing wt, XPCS, and TTD primary MEFs. UV-in-
duced gH2AX formation in nondividing cells reflects at least in
part NER incision activity and is reduced in XPA-deficient human
(O’Driscoll et al., 2003) and mouse cells (Theron et al., 2005).
gH2AX staining in XPCS cells was greater than that in wt cells
upon UV treatment (Figure 3E), indicative of an increased num-
ber of incisions despite reduced UDS. In TTD cells as in XPA
cells, reduced UDS activity was paralleled by a reduction in
gH2AX staining (Figure 3E). Thus, elevated levels of UV-induced
incisions uncoupled from repair synthesis (UDS) are a property
of XPCS but not TTD cells in both man and mouse.
Low UDS relative to wt may still suggest UV lesion removal but
at a reduced rate. We thus tested the kinetics of lesion removal
at locally UV-irradiated regions of the nucleus in human cell lines
including representative XPDXPCS, XPDXP, XPDTTD, wt, and TTD124cells defective in another TFIIH subunit, p8/TTD-A. UV-induced
DNA lesions were visualized directly using antibodies against 6-
4 photoproducts or indirectly by the accumulation of NER fac-
tors XPC and TFIIH (Table 2 and data not shown). Consistent
with earlier biochemical findings (van Hoffen et al., 1999), lesions
remained in XPDXP and XPDXPCS cells up to 8 hr following UV
treatment despite residual UDS levels w30%–40% of wt. In
TTD cells with 15%–50% residual UDS, however, lesions were
largely removed within 8 hr after UV. Thus, unlike in wt and
TTD cells, the low levels of repair synthesis (UDS) observed in
XPDXP and XPDXPCS cells do not represent actual lesion re-
moval. We now refer to this futile NER-related DNA synthesis ac-
tivity as ‘‘phantom’’ UDS. Taken together, these data suggest
that the unique UV-induced skin cancer predisposition ob-
served in XPCS mice may be caused by a combination of com-
mon and unique NER defects: namely, the failure to remove UV
lesions, a property shared with XPA deficiency, and uncoupled
cut and patch mechanisms resulting in both gH2AX foci and
phantom UDS, a property unique to XPCS.
CS-specific developmental and progeroid features
in XPCS mice
Developmental delay in CS-affected humans has an almost ex-
clusive postnatal onset (Nance and Berry, 1992). Although bornCANCER CELL AUGUST 2006
A R T I C L EFigure 3. Acute and chronic effects of UV-B on XPCS mice
A: Skin sections of the indicated genotypes following acute UV-B exposure. Note the pronounced epidermal hyperplasia (increased number of viable cell
layers; arrow above), hyperemia (dilated capillaries filled with blood; arrow below), and absence of a keratinized layer reflected by ‘‘scaling of the skin’’
at the macroscopic level. H&E; scale bars, 20 mm.
B: Time course of tumor formation in XPCS and XPA mice during chronic UV-B exposure.
C: Example of a typical squamous cell carcinoma invading subcutaneous tissues from a UV-B exposed XPCS mouse. H&E; scale bar, 160 mm.
D: UV-B-irradiated cornea of wt and XPCS mice as indicated. Note the squamous cell carcinoma in the eye of an XPCS mouse. H&E; scale bars, 80 mm.
E:Quantification of gH2AX immunofluorescence indicative of DNAbreaks in nuclei before (2) and 3 hr after (+) UV irradiation in primarywt, XPCS, TTD, and XPA
MEFs. 13 relative intensity represents the average amount of gH2AX immunofluorescence in the corresponding unirradiated cell line; cells with >23 this
amount were considered gH2AX positive. Error bars indicate SD.at the expected Mendelian frequencies and with normal birth
weights, XPCS mice displayed a small but significant develop-
mental delay present at about 5 days after birth and persisting
at least until 16 days for both male and female XPCS pups
(Figure 4A). While female XPCS mice caught up with littermate
controls between w2 and 4 weeks of age, the developmental
delay in male XPCS mice lasted until about 2 months of age (Fig-
ures 4B and 4C), during which tail suspension tests of male but
not female XPCS mice occasionally revealed spastic and ab-
normal coordination of hindlimbs (Figure 4D). No correlationCANCER CELL AUGUST 2006between the extent of developmental delay and neurological
features was observed. After 2 months, the neurological fea-
tures became less pronounced and gradually disappeared
among most, but not all, of the 20 male XPCS animals examined.
Gross behavior, cognitive ability, and neuromotor function of
XPCS mice were analyzed by behavioral tests. Although male
XPCS mice showed normal behavior, they were significantly
less active within the first minute of an open-field exploratory
test (n = 12 and 17 for XPCS and wt animals, respectively; p <
0.03), indicating that XPCS mice require longer adaptationTable 1. UV-induced tumorigenesis in XPCS mice
Tumor Incidence
Genotype wt or hz XPCS XPA Tumor types found (3 incidence)
UV-treated (at 17 weeks
after start of UV)
0/7 10/10*, average latency
13 weeks
0/5 SCC of an eye, 43 (cases);
83 SCC + 2 SCP of the skin;
hemangioma of an eye, 23
UV-treated (at 31 weeks
after start of UV)
0/7 (also at 41 weeks) — 5/5*, average latency
25 weeks
SCC of an eye, 13; 63 SCC + 13 SCP
of the skin
hz, XPCS heterozygous; SCC, squamous cell carcinoma; SCP, squamous cell papilloma. *Significant difference in average tumor latency time for XPCS mice
versus XPA mice, p < 0.0008.125
A R T I C L Etime in a new environment. No age-specific differences were
found up to 7 months of age, suggesting that within this age
range this feature has no progressive character (data not
shown). Next, neuromotor coordination and learning capacity
were examined with the accelerating rotarod test. XPCS mice
(n = 22) appeared normal. Footprint pattern analysis did not re-
veal any gait abnormalities (data not shown). Both male and fe-
male XPCS mice were fertile until at least 6 months of age and
produced litters of normal size (data not shown). However, lon-
gitudinal histological analysis revealed progressive loss of ger-
minal epithelium in the testis (Figure 4F). Cerebellum, in which
loss of Purkinje neurons is believed to contribute to ataxia in
CS patients, appeared unaffected in XPCS mice up to 19
months of age as concluded from immunohistochemical analy-
sis of Purkinje neurons using calbindin antibody staining (data
not shown).
We next addressed progeroid aspects related to the XPCS
mutation in a life span study with 45 wt and 46 XPCS animals.
Early cachexia (loss of subcutaneous fat tissue) is a common
segmental progeroid feature both in CS patients (Nance and
Berry, 1992) and in a mild form in CSB mice (H.v.S., unpublished
data). At 6 months of age, no significant difference in body
weight between wt and XPCS animals was noted. From 12
months onward, female XPCS mice displayed reduced body
weight (Figure 4C). Cachexia was also observed in three out of
four male XPCS animals that survived to 20 months of age,
with weights of 21, 28, 31, and 41 g, while none of the 18 control
animals were below 34 g (average 41 g; SE = 1 g) at that age.
The mean life span of XPCS mice (546 days; SE = 22.7) versus
control mice (641 days; SE = 43.3) was significantly reduced (log
rank p = 0.001). Animals judged to be in poor overall condition
and/or animals with obvious internal or external tumors were
sacrificed and autopsied. Although the percentage of mice
with tumors at the end of their lives was similar (73% in wt versus
80% in XPCS), the average life span of animals bearing tumors
at the time of sacrifice or autopsy was 5846 24.7 days in XPCS
versus 7446 39.2 days in wt animals (p < 0.002), suggesting an
earlier onset of spontaneous tumors in XPCS animals. Tumors
were observed in liver, lung, ovary, kidney, and lymph node of
wt animals, and in the liver, lungs, ovaries and testis, eye, and
Table 2. UDS and kinetics of damage removal in human XP, XPCS,
and TTD cells
Cell line
UDS, percent
of the wt
Relative XPC intensity
at local UV damage
15 min 8 hr
C5RO (wt) 100% +++ —
XP6BE (XPDXP) w40%d +++ +++
XP1NE (XPDXPCS) w40%a +++ +++
XPCS2 (XPDXPCS) w30%b +++ ++
TTD1BEL (XPDTTD) w15%c +++ —
TTD1RO (XPDTTD) w50%d +++ —
TTD1BR (p8TTD) w25%e +++ —
Note that UDS in wt (C5RO) is set at 100%. + indicates relative intensity of im-
munostaining signal of XPC (immunostaining of the p62 subunit of TFIIH and
6-4 photoproducts yielded similar results; data not shown).
aTaylor et al. (1997).
bTakayama et al. (1995).
cBroughton et al. (1994).
dTakayama et al. (1996).
eStefanini et al. (1993).126lymph node in addition to three papillomas of the skin in XPCS
mice.
CS and sensitivity to oxidative DNA damage
Although oxidative DNA damage has long been suspected in the
etiology of NER-related segmental progerias, solid supporting
data have been few (Cozzarelli, 2003). Cells deficient in TC-
NER due to CSB mutations (human and mouse) are hypersen-
sitive to acute oxidative stress such as that induced by gamma
irradiation or paraquat (de Waard et al., 2003, 2004; Spivak and
Hanawalt, 2006). We observed hypersensitivity of spontane-
ously transformed XPCS MEFs to g irradiation (Figure 5A) con-
sistent with a CS-type defect in the repair of oxidative DNA
damage.
Recently, SV40-immortalized CSA or CSB fibroblasts were
also shown to be defective in their ability to express a reporter
gene from a plasmid containing specific oxidative lesions
upon transient transfection (Spivak and Hanawalt, 2006). Be-
cause survival/proliferation assays are influenced by many fac-
tors in addition to DNA repair capacity, we further optimized this
host cell reactivation assay in order to more directly test the abil-
ity of NER-deficient cells to repair oxidative DNA lesions. We
employed a dual firefly/renilla luciferase readout with a damaged
renilla luciferase-encoding plasmid and an undamaged firefly
luciferase-encoding plasmid in order to better control for trans-
fection efficiency.
Ionizing irradiation was used to induce a spectrum of mainly
oxidative-type lesions for transfection into spontaneously im-
mortalized MEFs or SV40-immortalized human fibroblasts.
Both murine and human CS, TTD, and XPCS cells were less pro-
ficient at reactivating the luciferase-encoding plasmid than wt
(Figures 5B and 5C). Although small, differences were reproduc-
ible and significant. As a control, the ability of CS, TTD, and
XPCS cells to reactivate UV-irradiated plasmid correlated posi-
tively with the UV sensitivity of the corresponding genotypes,
with TTD cells closest to wt reactivation, CSB intermediate,
and XPCS least able to reactivate (Figures 5B and 5C, insets).
To determine if specific types of oxidative lesions within the
spectrum of ionizing radiation damage contributed to the differ-
ential reactivation capacity of NER mutants, we induced 8-oxoG
and thymine glycols in the reporter plasmid using OsO4 and
methylene blue with light, respectively. For each type of damage
in both human and mouse cells, wt cells were better able to re-
activate the reporter plasmid (Figures 5B and 5C, insets). How-
ever, due to small magnitudes and considerable interassay var-
iability, these differences reached statistical significance only in
XPCS for 8-oxoG (human) and TTD for thymine glycol (human
and mouse). We conclude that multiple types of oxidative
damage are likely to contribute to the reactivation deficiency
observed in these NER mutant cells.
Xpa ablation induces a similar phenotype in both XPCS
and TTD models
Previously, we found that further reduction of DNA repair capac-
ity in TTD mice by concomitant inactivation of Xpa severely ex-
acerbates TTD features. XPAjTTD double mutant mice are born
normally but display enhanced progressive postnatal growth
failure, disproportionally big head and limbs, kyphosis, ataxia,
spasticity, balance problems, gait anomalies, severe cachexia,
and death around 2–3 weeks of age (de Boer et al., 2002).
XPAjXPCS double mutant mice were born normally, ruling outCANCER CELL AUGUST 2006
A R T I C L EFigure 4. Phenotype of XPCS mice
A–C:Developmental delay in XPCSmice. Bodyweight of three independentgroupsof XPCSmiceweremeasuredat 5, 12, and16days (A) and from0.9 (45wt+
46 XPCS) to 20 months (C). Error bars indicate SEM. Note the smaller size of the male XPCSmouse (in front) compared to a littermate control at 0.9 months (B).
D: Tail suspension test of 6-week-old male mice. wt behavior includes spreading of hindlimbs and active movements with forelimbs. XPCS mice displayed
heterogeneous phenotype including abnormal clasping of hind- and forelimbs (depicted), occasional tremors, and complete inactivity upon tail suspension.
E: Accelerated appearance of cachexia and kyphosis in male XPCS mice at 19 months of age compared to an age-matched wt control.
F: Progressive loss of germinal epithelium in the testis of male XPCS mice. H&E; scale bars, 80 mm.impaired embryonal development (Figure 6B), and displayed
symptoms similar to XPAjTTD mice (Figures 6A and 6C and
data not shown). Growth failure in XPAjXPCS mice was not
due to impaired nursing, as double mutant mice were lactated
normally by the mother based on the presence of milk in the
stomach of the pups analyzed at 8–12 hr and 5, 12, and 20
days after birth (data not shown). Analogous to XPAjTTD mice,
life span could not be extended by providing newly lactating
mothers at the age of w20 days. Observational and footprint
analyses of XPAjXPCS mice revealed progressive disturbed bal-
ance, ataxia, gait abnormalities, tremors, and spasticity during
ongoing movements, suggesting that neurodysfunction in
XPAjXPCS and XPAjTTD double mutant mice is similarly
dramatically more pronounced than that in either of the single
mutant TTD or XPCS animals. Neuropathological analyses
of XPAjXPCS mice using a variety of stainings (i.e., acetyl-
choline esterase, silver and Nissle stainings, as well asCANCER CELL AUGUST 2006immunohistochemical detection of calbindin, dopamine, and ty-
roxine hydroxylase) revealed a loss of Purkinje cells at the age of
20 days (Figure 6D). This included loss of both proximal and dis-
tal dendrites as well as cell bodies and is indicative of a degen-
erative process. The morphology of the remaining Purkinje cells
at 20 days of age looked relatively normal with a characteristic
two-dimensional dendritic tree reaching the top of the molecular
layer; calbindin staining indicated an average reduction of Pur-
kinje cells to 69% (6 18%) in the vermis and 31% (6 14%)
in the hemispheres. The silver-stained sections of day 20
XPAjXPCS mice did not reveal any prominent evidence for sec-
ondary degeneration in the granule cell layer or inferior olive.
This suggests that the maximal age period ofw3 weeks is insuf-
ficient to allow such a degenerative process to progress beyond
the loss of Purkinje neurons. In addition, we did not observe any
degeneration in higher brain regions such as the striatum, hippo-
campus, cerebral cortex, or thalamus as reported for several127
A R T I C L Ecases of CS in humans (Itoh et al., 1999; Lindenbaum et al.,
2001).
Discussion
Recapitulation of the XPCS phenotype in mice
Existing mouse models of CS, including CSB and CSA mice,
as well as TTD mice, mimic the respective human syndromes
but generally display milder disease symptoms (van der Horst
et al., 1997, 2002; de Boer et al., 1998a). Possibly this is due
to species-specific differences in the DNA damage response
and/or time frame (see below). Consistent with this, XPCS
mice displayed developmental delay and mild segmental aging
features, including cachexia and testicular atrophy. XPCS mice
also had a shorter mean life span—a phenotype likely at least in
Figure 5. Oxidative DNA damage repair characteristics of XPCS cells
A: Representative ionizing radiation survival curve of two independent
spontaneously immortalized XPCS MEF lines (indicated by the numbers).
Error bars indicate SEM within the experiment.
B and C: Host cell reactivation in spontaneously immortalized MEFs (B) and
SV40-transformed patient cells (C) of the indicated genotypes. Luciferase-
encoding plasmid DNA was treated with ionizing radiation of the indicated
dose (gy) or with OsO4 to generate thymine glycols, methylene blue with
light to generate 8oxoG, or 400 J/m2 UV-C (insets) as indicated. Error bars in-
dicate SEM between three and four independent experiments. Differences
between wt and XPCS and TTD (mouse and human) or CSB (mouse) were
statistically significant (p < 0.05) at at least two doses of ionizing radiation.128part related to an earlier onset of spontaneous cancers. XPCS
cells revealed molecular characteristics of DNA damage repair
strikingly similar to human XPDG602D cells, including reduced
TC-NER capacity, residual UDS activity in the absence of lesion
removal, altered NER complex dynamics, reduced UV and ion-
izing radiation resistance, and reduced host cell reactivation of
UV- and oxidative-type DNA lesions. Furthermore, XPCS mice
displayed an extreme UV-induced cancer predisposition as in
the human XPDG602D patient. Thus, the patient-based XPDG602D
point mutation recapitulated in mice many elements of both the
xeroderma pigmentosum and Cockayne syndrome compo-
nents of the combined disorder.
It is important to note that XPCS mice did not display the hall-
mark features of TTD that set it apart from XPCS, notably brittle
hair, ichthyotic skin, and anemia (data not shown), despite re-
duced levels of TFIIH in fibroblasts. This provides strong evi-
dence that specific point mutations in the human XPD gene
and its mouse counterpart result in precise pathologies in both
man and rodents.
Figure 6. XPA ablation exacerbates segmental progeroid features of XPCS
mice
A: Body weights of four independent cohorts of mice measured at w20 hr
after birth and at 5, 12, and 16 days of age. Error bars indicate SEM.
B and C: Light and X-ray photographs of XPAjXPCS (left) and littermate
control (right) micew20 hr (B) and 20 days (C) after birth demonstrate the
postnatal and progressive nature of cachexia and reduced bone mineral
density in XPAjXPCS mice.
D: Loss of Purkinje cells in the cerebellum of XPAjXPCSmouse but not in litter-
mate control at the ageof 20 days. Arrows indicate Purkinje cell bodies. Cal-
bindin immunostaining; scale bars, 80 mm.CANCER CELL AUGUST 2006
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and TTD
Although a number of underlying disease mechanisms have
been put forth to explain XPD disorders, we favor the notion
that DNA repair of transcription-blocking lesions is a primary de-
terminant of progeria in both XPCS and TTD. This notion initially
gained traction with the genetic finding that a further reduction
of DNA repair capacity in TTD and CSB mice by XPA inactivation
results in accelerated progeroid features and a reduced life span
of 2–3 weeks (de Boer et al., 2002; Murai et al., 2001). Here, we
present further evidence in support of the hypothesis that a com-
mon disease mechanism rooted in defective DNA repair under-
lies the segmental progeroid features shared by TTD and XPCS.
First, we reasoned that if the basic mechanisms of progeroid
disease in XPCS and TTD were different (e.g., if a TCR deficit ex-
plains CS and a gene-specific transcriptional activation insuffi-
ciency causes the premature aging in TTD), then inactivation
of the exclusively NER-associated Xpa gene would likely result
in different phenotypes in double mutant XPAjXPCS versus
XPAjTTD mice. On the contrary, we found a phenotypic overlap
between XPAjXPCS and XPAjTTD mice, including progressive
postnatal growth failure, disproportionally large head and limbs,
kyphosis, ataxia, spasticity, balance problems, cachexia, and
death around 2–3 weeks of age. A similar phenotype was ob-
served upon further inactivation of DNA repair capacity (by ge-
netic ablation of the Xpa or Xpc gene) in mouse models of CS,
including XPAjCSB, XPAjCSA, and XPCjCSB double mutant
mice (Friedberg and Meira, 2004; Murai et al., 2001; van der
Horst et al., 2002). A similar phenotype is also present in mice
lacking the XPCS-associated Xpg gene (Sun et al., 2001). The
overlapping phenotypes of mice with single or double homozy-
gous mutations in various NER-associated genes are strongly
suggestive of defective DNA repair, rather than defects in tran-
scription associated with specific Xpd point mutations, as caus-
ative of the severe developmental phenotypes resembling the
progeroid disorders CS and TTD in humans. Recent evidence
of functional interactions between XPG, CSB, and stalled RNA-
PII in vitro and in vivo lend further support to this conclusion
(Sarker et al., 2005).
Second, we found that XPAjXPCS and XPAjTTD cells share
a common deficit in the spatiotemporal organization of the
GG-NER reaction at local UV-induced damage. Although GG-
NER capacity does not correlate with segmental progeria, muta-
tions affecting GG-NER components may result in similar spa-
tiotemporal alterations of the NER reaction in response to
more relevant damage types such as oxidative lesions.
Finally, spontaneously immortalized XPCS MEFs and SV40-
immortalized XPCS patient-derived fibroblasts, like the cor-
responding TTD and CSB cells, were defective in host cell
reactivation of ionizing radiation-induced DNA damage. This is
important because neither human nor mouse TTD cells have
been reported to be hypersensitive to acute oxidative stress
(de Boer et al., 2002), confounding any interpretation of the rela-
tionship between endogenous oxidative DNA damage and NER-
associated progerias. Although ionizing radiation can break the
DNA sugar-phosphate backbone directly, most damage is due
to oxidation of the bases by reactive oxygen species including
hydroxyl radicals (Riley, 1994). These DNA lesions can be subtle
base modifications and typical base excision repair substrates
(e.g., 8-oxoG and thymine glycol). Some are, however, helix dis-
torting and thus typical NER targets (e.g., 8,50-cyclo-20-CANCER CELL AUGUST 2006deoxyadenosine). Combined with the known role of NER in
host cell reactivation of helix-distorting oxidative lesions (Brooks
et al., 2000), our data suggest that both helix-distorting and non-
distorting oxidative lesions are affected in CS, XPCS, and TTD
alike. Finally, the small differences in host cell reactivation of ox-
idative lesions between man and mouse suggest that interspe-
cies differences in the severity of NER-associated progerias
may emerge from species-specific responses to such damage.
Molecular mechanism of cancer predisposition in XPCS
versus TTD
Our data suggest that reduced longevity of XPCS mice is related
at least in part to enhanced spontaneous internal tumor inci-
dence similar to that observed both in XP patients (Kraemer
et al., 1987) and the XPA mouse model (H.v.S., unpublished
data). Because XP can result from defects in either NER (XPA-
XPG) or error-free lesion bypass (XPV), the ultimate cause of mu-
tations underlying the skin cancer predisposition of XP patients
and mice is thought to be DNA replication over unrepaired UV
lesions by error-prone bypass polymerases. Although species-
specific differences in cancer induction and control of repair
(e.g., p53 control of XPE expression (Tang and Chu, 2002) per-
haps complicate direct human-mouse comparisons, assess-
ment among NER mutant mice is feasible. Surprisingly, we
found that XPCS mice with apparent residual cellular NER activ-
ity (30% of wt UDS) appeared even more cancer prone than
completely NER-defective XPA mice upon chronic exposure
to UV-B. This is in sharp contrast to TTD mice, which exhibit
a lower spontaneous tumor incidence than wt mice (Wijnhoven
et al., 2005), are only mildly cancer prone when exposed to
a high dose of UV-B (Table S1) (de Boer et al., 1999), and
were cancer free when exposed to a comparably low dose
(80 J/m2/day; J.J. and H. Rebel, unpublished data).
Several observations suggest a molecular defect specific to
XPCS that makes it worse than lacking NER capacity altogether.
First, unlike in TTD and other NER-deficient cells, repair synthe-
sis (as measured by UDS) failed to correlate with lesion removal
specifically in XPDXPCS and XPDXP cells and thus does not rep-
resent actual repair. Based on its localization within locally UV-
irradiated regions of the nucleus (data not shown), this phantom
UDS may instead reflect DNA synthesis in the area of the dam-
age but apart from the lesion itself, for example, on the undam-
aged strand opposite a lesion. Such a process would require the
use of the damaged strand as a template and could lead directly
to mutations.
Increased DNA incisions following UV damage, on the other
hand, occurs specifically in cells from XPDXPCS patients (Berne-
burg et al., 2000), though any physiological relevance has
remained unclear. As shown here, a similar increase in UV-
induced incisions occurs in cells from XPCS mice, indicating
the consistent cross-species nature of this specific characteris-
tic. We propose that the accelerated cancer induction in XPCS
mice, compared to fully NER-deficient XPA mice, results from
the well-known mutagenic and cytotoxic potential of persistent
DNA strand breaks superimposed on the mutagenicity resulting
from unrepaired bulky DNA adducts. The elevated genomic in-
stability in XPCS may trigger cancer predisposition, whereas
the enhanced cytotoxicity may contribute to the observed seg-
mental progeria.
In summary, the TTD phenotype, in which aging is enhanced
and spontaneous cancer reduced, supports the general notion129
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cancer. However, the XPCS mouse described here demon-
strates that these processes are not always antagonistic, since
both cancer as well as aging as different outcomes of DNA dam-
age are enhanced at the same time. Intriguingly, these disparate
phenotypes are the consequence of different point mutations in
the same multifunctional gene XPD.
Experimental procedures
Derivation of mutant mice and mouse embryonic fibroblast lines
Derivation of Xpa2/2 (XPA), Csb2/2 (CSB), and XpdTTD/TTD (TTD) mice and
cells was described previously (de Boer et al., 1998a; de Vries et al., 1995;
van der Horst et al., 1997). Details of the XPCS targeting construct will be pro-
vided upon request. Electroporation, culturing, and routine screening of 129/
Ola-derived ES cells were performed as described previously (de Boer et al.,
1998a). Heterozygous XpdXPCS-neoLoxP ES cells were transiently transfected
with Cre recombinase cDNA under puromycin selection in order to test ex-
pression from the targeted versus wt alleles by RT-PCR. Blastocyst injection
and subsequent matings were performed by standard methods. Chimeras
were mated with C57BL/6 mice; heterozygous progeny were intercrossed
with FVB transgenic CAG-cre mice (Sakai and Miyazaki, 1997) yielding het-
erozygote XpdXPCS mice without the pMC-1 neo-LoxP cassette (Figure 1C).
The presence of the G602D mutation and the absence of any other undesired
mutations originating from cloning or gene targeting were verified by se-
quencing of cDNA from the targeted allele (BaseClear Group, The Nether-
lands). Standard genotyping for XpdXPCS mice was performed using primers
F2 (50-GGGAGCAGCTGCAGTCA-30) and R (50-GCAGGGCATGAAGTGGC
TCC-30) yielding a 400 bp wt product and a 529 bp product from the targeted
allele following Cre recombination. Mice used in this study were in a 129Ola/
C57BL/6/FVB mixed background unless noted differently. All experiments
involving mice were judged and approved by the National Committee for
Genetic Identification of Organisms and the Animal Ethical Committee and
were conducted according to national and international guidelines.
Cellular DNA damage assays
UV-induced UDS and RRS as well as UV and gamma ray survival assays
were performed as described previously (de Waard et al., 2003; Vermeulen
et al., 1994). For UV survival, two to four experiments using at least two inde-
pendent, early passage (2–5) primary MEF cell lines per genotype were per-
formed. For gamma ray survival, two experiments using two independent
spontaneously transformed cell lines per genotype were performed. Host
cell reactivation was adapted from Spivak and Hanawalt (2006). Plasmid
DNA (TK-firefly luciferase, CMV-renilla luciferase) was prepared by the alka-
line lysis method using a Nucleobond AX kit. Damage was introduced into the
CMV-renilla luciferase plasmid by treatment with UV-C (100 or 400 J/m2),
gamma rays from a cesium source (12.5–100 gy), visible light from a tungsten
lamp for 0–36 min in the presence of 5 mM methylene blue, or addition of
0.5%–1.5% osmium tetraoxide at 65C for 5 min. Methylene blue was re-
moved by ethanol precipitation; osmium tetraoxide was removed by over-
night dialysis in water. Cells (1–2 3 104) of log-phase cultures were seeded
per well of a 96-well plate and transfected the next day with 400 ng undam-
aged internal control plasmid and 20 ng damaged plasmid in 5 ml Optimem I
media (Gibco Invitrogen) with 0.2 ml Fugene 6 transfection reagent (Roche)
according to the manufacturer’s instructions. Firefly and renilla luciferase ac-
tivities were measured 24 hr after transfection using the Promega Dual Lucif-
erase Reporter Kit (E1960) according to the manufacturer’s instructions. The
following number of independent MEF lines was used: four wt, three XPCS,
three TTD, two CSB. Patient-derived, SV40-transformed fibroblasts were as
follows: two normal (CR50, VH10); two XPCS (XPCS2, XP8BR); two TTD
(TTD1RO, TTD1BR); one CSB (CS1AN).
Immunohistopathology of the brain
Animals were anaesthetized (Nembutal; 50 mg/kg) and perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer. Sucrose-cryoprotected, gela-
tin-embedded brains were cut in 40 mm sagittal or coronal sections (one-half
brain each). Nissl staining, acetylcholine esterase staining, and silver stain-
ings were done according to standard procedures. Immunocytochemistry
was performed in 0.1 M Tris-buffered saline using rabbit antibodies against130calbindin (Sigma), dopamine (Mark), or tyroxine hydroxylase (Novus) diluted
1:1000 for 72 hr. Quantitative analyses of Purkinje cells were done with Neu-
rolucida, NeuroExplorer, and analySIS software.
Comparative immunofluorescence analysis of the p62 subunit
of TFIIH and local UV damage-related assays
Latex bead labeling and comparative immunofluorescence analysis of the
p62 subunit of the TFIIH was performed as described previously (Botta
et al., 2002; Vermeulen et al., 2000). Local UV damage induction and subse-
quent immunostaining was performed as described previously (Mone et al.,
2001; Volker et al., 2001). UDS at locally irradiated domains in the nucleus
was performed as described previously (Volker et al., 2001), except radio-
active labeling for time point analysis was started immediately or 6 hr after
UV irradiation for a period of 2 hr each. For gH2AX staining, at least 50 cells
for each time point and genotype were randomly chosen. Of these, total
nuclear intensity of gH2AX signal was measured using Adobe Photoshop.
Allelic composition of mutant cell lines depicted in Table 2 are as follows:
XP6BE = XPDdel36-61/R683W; TTD1RO = XPDR658C/G713R; TTD1BR =
p8R56stop/L21P; TTD1BEL = XPDR722W/R616P; XP1NE = XPDG47R/L461V+del716-730.
Supplemental data
The Supplemental Data include one supplemental table and can be found
with this article online at http://www.cancercell.org/cgi/content/full/10/2/
121/DC1/.
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